BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16

• Press Releases

  ADLM publishes first comprehensive U.S. guidance to help laboratory medicine professionals meet the needs of gender diverse patients

  July 1, 2026

   · 

  4 min read
• Press Releases

  Clinical Trial of Shigella Vaccine Shows 89% Protection

  July 1, 2026

   · 

  3 min read
• Press Releases

  92Bio, Inc. Doses First Patient in Phase 1 Clinical Trial of NTB-928 in Platinum-Resistant Ovarian Cancer

  July 1, 2026

   · 

  3 min read
• Press Releases

  Tenon Medical, Inc. Announces Closing of $4.2 Million Public Offering

  July 1, 2026

   · 

  6 min read
• Press Releases

  Colossal Foundation Partners With University of Tasmania on Vaccines and Gene Editing to Fight Devil Facial Tumour Disease

  July 1, 2026

   · 

  3 min read
• Press Releases

  FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients

  July 1, 2026

   · 

  3 min read
• Press Releases

  Knoa Pharma Board Appoints Michael Goettler as President and Chief Executive Officer

  July 1, 2026

   · 

  2 min read
• 

  IN PARTNERSHIP WITH CERTARA

  Webinar: Streamlining Nonclinical Development with FDA NAMs

  FDA’s draft guidance on the validation of non-animal methods (NAMs) is reshaping how nonclinical programs are designed and justified. This webinar explores how sponsors can apply NAMs to streamline development, improve human relevance, and support IND decision-making within a weight-of-evidence framework.
  

  July 1, 2026

   · 

  1 min read

   · 

  BioSpace Insights
• Press Releases

  AOB Pharma and Biorasi to Partner to run Phase 2b in Moderate to Severe Acne

  July 1, 2026

   · 

  4 min read
• Press Releases

  Fate Therapeutics to Participate in Upcoming Third Quarter 2026 Conferences

  July 1, 2026

   · 

  1 min read